Connection

Scott Sullivan to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Scott Sullivan has written about Cost-Benefit Analysis.
Scott Sullivan
Connection Strength
0.043
Cost-Benefit Analysis
  1. Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. J Med Econ. 2022 Jan-Dec; 25(1):1255-1266.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.